Market Overview

UPDATE: Morgan Stanley Downgrades Cerner Corporation to Equal-Weight on Bookings Deceleration

Share:
Related CERN
Morning Market Losers
Benzinga's Top Downgrades
Cerner & Hospira to Enhance I.V.-EMR Technology Integration (Zacks)

Morgan Stanley reduced its rating on Cerner Corporation (NASDAQ: CERN) from Overweight to Equal-weight and removes its prior price target of $82.

Morgan Stanley commented, "Challenging y/y comparisons, associated with approaching deadlines for attesting to Stage 1 Meaningful Use, should lead to slower bookings growth by 2013. With shares trading at a premium to historical valuation and to the broader software group, we see limited upside potential in the near-term."

Cerner Corporation closed at $73.75 on Thursday.

Latest Ratings for CERN

DateFirmActionFromTo
Aug 2015Stifel NicolausDowngradesHoldSell
Aug 2015RBC CapitalDowngradesOutperformSector Perform
Jun 2015OppenheimerInitiates Coverage onOutperform

View More Analyst Ratings for CERN
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Downgrades Price Target Intraday Update Analyst Ratings

 

Related Articles (CERN)

View Comments and Join the Discussion!

Get Benzinga's Newsletters